Delivery Order SPE2DB22D1002-SPE2DB25FLBW3
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,418.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 10, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,298.24, is a delivery order for the provision of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, with a ceiling value of $22,309.20. It is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $11,966.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Dupixent 300 mg/2 ml pen, a prescription medication. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $42,785.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml pens, with an ultimate completion date of May 6, 2025. The contract type is Firm Fixed Price, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB25D3017|SPE2DB25FVHTK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,584.78 and a performance period extending through April 17, 2025. The contract is not set-aside and was awarded as part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB25D3021|SPE2DB25FQYFK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,684.04 firm fixed-price delivery order is for the supply of 4,567,984,613 units of the medication Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of April 22, 2025 and was awarded on April 21, 2025. This delivery order is part of Amerisourcebergen's...
This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJLP8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,855.58 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a medication used for medical treatments. The contract has an ultimate completion date of April 28, 2025 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FP01B, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,084.55 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a medication used to treat certain medical conditions. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization based in Conshohocken,...
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FETQZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,081.43 firm-fixed-price delivery order covers the supply of Dupixent 300 mg/2 ml pen for a period ending on January 31, 2025. This contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...